HCM
HUTCHMED (China) Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$14.09
−0.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 56.65x
- P/E 2027E
- 33.57x
- P/E 2028E
- 27.21x
- P/S forward
- 3.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- 143.78x
- PEG TTM
- —
- Price / book
- 1.95x
- Price / sales
- 4.48x
- Price / cash flow
- 120.15x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.17x
- EV / EBITDA
- -58.03x
- EV / EBIT
- -34.23x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026